An Australian man set a medical milestone by living 100 days with a titanium artificial heart while waiting for a transplant.

Fauna Bio, a biotech that mines data on disease resistance from squirrels and other animals to create new drugs, is looking ...

The patient, a man in his 40s from New South Wales, received the BiVACOR Total Artificial Heart (TAH) during a six-hour ...

AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update Landmark exclusive option and license deal with Takeda for ACI-24.060 with $100 million upfront and additional potent ...

Danon disease is a rare but serious cardiomyopathy that drastically reduces life expectancy. Male patients infrequently live ...

Landmark exclusive option and license deal with Takeda for ACI-24.060 with $100 million upfront and additional potential milestones of up to about $2.1 billion plus royalties on sales upon ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India ...

Empagliflozin is an SGLT-2 (Sodium-Glucose Co-Transporter-2) inhibitor indicted for use in the treatment of type-2 diabetes mellitus.

By Karen Roman Biopharmaceutical company Medera Inc. said it finished patient dosing in the trial of SRD-001, its gene therapy candidate for heart failure with reduced ejection fraction. Additionally, ...

With prescription drug abuse still a pressing issue across the United States, Chesterfield County is providing free medication disposal pouches and locking bags, which are available while supplies ...

More frequent placement of central venous catheter seen for patients with heart failure with reduced ejection fraction.